Question 1

Can I get life insurance with hypothyroidism?

Accepted Answer

Yes — and typically without any rate impact at all. Well-controlled hypothyroidism with a normal TSH level on stable levothyroxine dosing is treated by most underwriters as essentially standard risk. Preferred Plus rates are achievable for hypothyroid applicants who are otherwise healthy. The condition is one of the most benign in life insurance underwriting when controlled.

Question 2

Does taking thyroid medication affect my life insurance rates?

Accepted Answer

No. Levothyroxine for hypothyroidism does not negatively affect your rate class. Carriers evaluate the outcome — your TSH level and overall health — not the fact that medication is required to achieve it. An otherwise healthy applicant on levothyroxine with a normal TSH is treated identically to an applicant without thyroid disease at most carriers.

Question 3

Can I get life insurance after thyroid cancer?

Accepted Answer

Yes, in most cases. Papillary thyroid cancer — the most common type — has an excellent prognosis and is one of the most favorably underwritten cancer histories. Standard rates are often achievable within one to two years of successful treatment with no evidence of recurrence. Follicular thyroid cancer is also generally favorable. Medullary and anaplastic thyroid cancers are much more restrictive.

Question 4

How does hyperthyroidism affect life insurance underwriting?

Accepted Answer

Active, uncontrolled hyperthyroidism carries cardiovascular risk — particularly atrial fibrillation — that causes underwriters to postpone applications until control is achieved. Hyperthyroidism successfully treated with radioactive iodine or thyroidectomy, resulting in stable hypothyroidism controlled with levothyroxine, is viewed very favorably. Most carriers require six to twelve months of stable post-treatment thyroid function before making their best offers.

Question 5

What TSH level do life insurance underwriters want to see?

Accepted Answer

Underwriters want to see a TSH within the normal reference range, typically 0.4 to 4.0 mIU per liter, on a stable levothyroxine dose. A significantly elevated TSH suggests undertreated hypothyroidism. A suppressed TSH raises concern about hyperthyroidism or over-replacement. Consistent normal TSH values over the past one to two years is the most favorable presentation.

Thyroid Condition	Typical Rating	Best Achievable	Notes
Hypothyroidism, controlled on levothyroxine, normal TSH	Standard to Standard Plus	Preferred Plus at many carriers	Treated as essentially normal risk by most underwriters
Hyperthyroidism, treated with RAI or surgery, stable	Standard	Standard Plus once stable	6–12 months of stability post-treatment typically required
Papillary thyroid cancer, treated, 1–2 years post-treatment	Standard to Table 2	Standard at select carriers after 1 year	Excellent prognosis; most favorable cancer underwriting scenario
Active uncontrolled hyperthyroidism	Postponement	Postponement until controlled	Cardiovascular risk from uncontrolled hyperthyroidism triggers postponement

Life Insurance with Thyroid Disease | Hypothyroidism Life Insurance | High Risk

What Underwriters Evaluate for Thyroid Disease

Thyroid Condition: General Underwriting Outlook

Thyroid Condition? You Likely Qualify at Standard Rates.

Browse All High-Risk Conditions

Ready to Protect What Matters Most?